Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders

Cellular therapy

Prolotherapy

Intragastric hypothermia using gastric freezing

Iv chelation therapy (chemical endarterectomy)

Fabric wrapping of abdominal aneurysm

Pain screened as moderate to severe

Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician

Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given

Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for ra

Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)

Tb screening not performed or results not interpreted, reason not given

Disease activity not assessed, reason not given

>=50% of total number of a patient's outpatient ra encounters assessed

<50% of total number of a patient's outpatient ra encounters assessed

Discharge/discontinuation of the episode of care documented in the medical record

Discharge/discontinuation of the episode of care documented in the medical record

Discharge/discontinuation of the episode of care documented in the medical record

Discharge/discontinuation of the episode of care documented in the medical record

Discharge/discontinuation of the episode of care documented in the medical record

Discharge/discontinuation of the episode of care documented in the medical record

Discharge/discontinuation of the episode of care documented in the medical record

Female patients unable to bear children

Patient admitted to palliative care services

Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients

Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5

Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5

Patient had only urgent care visits during the performance period

Patients who were in hospice at any time during the performance period

Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five

Patients who were in hospice at any time during the performance period

Patients who were in hospice at any time during the performance period

Imaging of the head (ct or mri) was obtained

Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained

Imaging of the head (ct or mri) was not obtained, reason not given

Patients with clinical indications for imaging of the head

Patients with no clinical indications for imaging of the head

Adults currently taking pharmacotherapy for oud

Pharmacotherapy for oud initiated after june 30th of performance period

Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days

Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment

Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days

Patients with a diagnosis of lumbar spine region cancer at the time of the procedure

Patients with a diagnosis of lumbar spine region fracture at the time of the procedure

Patients with a diagnosis of lumbar spine region infection at the time of the procedure

Patients with a diagnosis of lumbar idiopathic or congenital scoliosis

Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis

Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively

Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37

Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37

Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively

Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis

Leg pain was not measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively

Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively

Patient had only urgent care visits during the performance period

Aspirin or another antiplatelet therapy used

Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease

Aspirin or another antiplatelet therapy not used, reason not given

Patient was a permanent nursing home resident at any time during the performance period

Patient was in hospice or receiving palliative care at any time during the performance period

Patient died prior to the end of the performance period

Patient pregnancy

Patient immunocompromised

Patients receiving high doses of immunosuppressive therapy

Shingrix vaccine documented as administered or previously received

Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

Shingrix vaccine not documented as administered, reason not given

Hospice services for patient provided any time during the measurement period

Adults who are not ambulatory

Patient screened for future fall risk

Patient not screened for future fall risk, reason not given

Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy